The Molar Report
The Molar Report
Pearl
Visit Website
Pearl dental software logo

Pearl Review

FDA-cleared AI that detects pathology on 2D and 3D dental radiographs, with the first dual 2D/3D clearance in dentistry

CloudEst. 2019Los Angeles, CAUpdated Apr 2026Visit website

Our Verdict

Pearl is the undisputed leader in dental AI diagnostics. Founded in 2019 by serial entrepreneur Ophir Tanz and backed by $58 million in Series B funding, Pearl has built something genuinely rare in dental tech -- an AI product with multiple FDA clearances, real clinical validation, and integrations across 30-plus imaging and PMS platforms. If you have ever squinted at a bitewing and wondered whether that shadow is early caries or an artifact, Pearl's Second Opinion wants to be your second set of eyes. The question is whether the ROI justifies adding another subscription to your stack.

4.5/ 5.0
Outstanding

Best For

Any practice that wants AI-assisted radiograph analysis to catch missed pathology and improve case acceptance. Especially valuable for DSOs standardizing clinical quality across locations.

Quick Summary
VendorPearl
Founded2019 — now powering 23,000+ practices
DeploymentCloud-based
User ratings4.3/5 on Capterra
Key strengthThe first and only dental AI with FDA clearance for both 2D and 3D imaging, with 94-95% pathology detection accuracy and integrations across 30+ platforms.
PricingCustom-quoted per location
Getting startedFree personalized demo

Full Review


What Is Pearl?

Pearl is an AI-powered dental diagnostics platform that analyzes radiographic images in real time, flagging pathology that the human eye might miss. The company's flagship product, Second Opinion, uses deep learning models trained on millions of dental images to detect up to 18 distinct findings per image -- including caries, periapical radiolucencies, bone loss, calculus, defective margins, fractures, root canals, crowns, bridges, and implants.

Pearl now holds FDA 510(k) clearance for three distinct capabilities: Second Opinion for periapical and bitewing radiographs, Second Opinion for panoramic radiographs (cleared December 2025), and Second Opinion 3D for CBCT imaging. That makes Pearl the first and only dental AI company cleared by the FDA for both 2D and 3D image analysis. Clinical validation studies show 94-95% accuracy in pathology detection.

Beyond diagnostics, Pearl has expanded into practice analytics with Practice Intelligence, a dashboard that analyzes clinical quality, financial performance, appointment metrics, case acceptance rates, and production by provider -- all in real time.


Who Is It For?

Pearl works for any practice that takes dental radiographs, which is essentially every practice. The sweet spot is mid-size to large practices and DSOs where the volume of images makes AI-assisted detection most valuable. Coast Dental, an 88-location DSO serving nearly one million patients annually, deployed Pearl across its entire network.

Solo practitioners benefit too, especially those without an associate to bounce diagnostic questions off of. The AI acts as a perpetual second opinion, catching things you might miss at 4 PM on a Friday after 30 patients.

Pearl integrates with over 30 imaging and PMS platforms globally, including Curve Dental (80,000-plus users), Oryx, Medit Link, and others. The company holds regulatory clearance in 120 countries across six continents, so international DSOs can standardize on a single AI platform.


Key Features

Second Opinion (2D): Real-time AI overlay on periapical, bitewing, and panoramic radiographs. Detects caries, bone loss, periapical radiolucencies, calculus, defective restorations, and more. Color-coded annotations appear directly on the image so you can walk patients through findings chairside.

Second Opinion 3D: Extends AI analysis to CBCT scans. Automatically identifies anatomical structures -- dentition, maxilla, mandible, inferior alveolar canal, mental foramen, maxillary sinus, nasal space, and airway. Saves significant time on 3D treatment planning.

Practice Intelligence: Analytics dashboard tracking clinical quality scores, financial performance, case acceptance, production by provider, and appointment utilization. Identifies revenue leaks and clinical gaps across your practice or DSO.

Patient Communication: AI-annotated images make it dramatically easier to explain findings to patients. Practices report improved case acceptance because patients can see what the AI detected, not just take the dentist's word for it.


Pricing

Pearl does not publish pricing. The company offers flexible monthly subscriptions with volume-based pricing, meaning larger practices and DSOs pay less per unit. A 30-day free trial is available, which is generous enough to evaluate the product properly.

Practices using Pearl report an average of $15,000 more in monthly production and 20-plus hours saved per week. If those numbers hold for your practice, the ROI math works even at a premium price point.


Pros

  • First and only dental AI with FDA clearance for both 2D and 3D imaging
  • 94-95% pathology detection accuracy backed by clinical studies
  • Integrates with 30-plus imaging and PMS platforms
  • Dramatically improves case acceptance through visual AI annotations
  • Practice Intelligence adds analytics beyond just diagnostics
  • 30-day free trial lets you evaluate before committing

Cons

  • No published pricing -- you have to talk to sales
  • Requires an internet connection for cloud-based AI processing
  • Value depends heavily on your image volume and case acceptance baseline
  • Another subscription on top of your PMS and imaging software
  • Practice Intelligence is a newer product with less track record
  • Small practices with low radiograph volume may not see enough ROI

The Bottom Line

Pearl is the real deal in dental AI. The FDA clearances, the clinical validation, and the breadth of integrations put it in a different league from the AI features being bolted onto PMS platforms. If you take a meaningful volume of radiographs and want to catch more pathology, improve case acceptance, and reduce diagnostic liability, Pearl is the first product you should evaluate. The lack of transparent pricing is the main friction point -- but the free trial means you can prove the value before you commit.

This review is based on publicly available information, user reviews, and independent research. The Molar Report does not accept payment for editorial placement or rankings. Read our editorial policy. Something look off? Let us know.


Software Match Quiz

Practice

Software

Pain Points

Must-Haves

Report

How big is your practice?

This helps us recommend software that fits your scale.

Stay informed

Stay in the loop

New reviews, pricing updates, and vendor changes — we'll let you know when it matters.